Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Pharmaceutical Materials, Inc., 2579-2580 [2019-01507]
Download as PDF
<![CDATA[
2579
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of these registrants to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each of the company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed companies.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
The registrant listed below
has applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of various classes of
schedule II controlled substances.
[FR Doc. 2019–01501 Filed 2–6–19; 8:45 am]
SUPPLEMENTARY INFORMATION:
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
SUMMARY:
The
company listed below applied to be
registered as a bulk manufacturer of
various basic classes of controlled
substances. Information on a previously
published notice is listed below. No
comments or objections were submitted
for the notice.
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Notice of registration.
Company
FR Docket
Published
Janssen Pharmaceuticals, Inc ..........................................................................................................................
83 FR 55205
November 2, 2018.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of this registrant to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed company.
Dated: January 7, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–01502 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Kinetochem,
LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 8, 2019.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on August
17, 2018, Kinetochem, LLC., 111 W
Cooperative Way, Ste. 310–B,
Georgetown, Texas 78626 applied to be
registered as a bulk manufacturer for the
basic classes of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled
substance
DATES:
VerDate Sep<11>2014
17:23 Feb 06, 2019
Jkt 247001
Marihuana .................
PO 00000
Frm 00093
Fmt 4703
Drug
code
7360
Sfmt 4703
Schedule
I
Controlled
substance
Tetrahydrocannabinols.
Drug
code
7370
Schedule
I
The company plans to manufacture
drug codes 7360 (marihuana) and 7370
(tetrahydrocannabinols), in bulk for
distribution and sale to its customers.
The company plans to synthetically
manufacture these drugs. No other
activities for these drug codes are
authorized for this registration.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–01509 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey Pharmaceutical Materials, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 8, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
DATES:
E:\FR\FM\07FEN1.SGM
07FEN1
2580
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
Morrissette Drive, Springfield, Virginia
22152.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
November 8, 2018, Johnson Matthey
Pharmaceutical Materials, Inc., 25
Patton Road, Devens, Massachusetts
01434 applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled
substances
Amphetamine ...........
Methylphenidate .......
Nabilone ...................
Hydrocodone ............
Levorphanol ..............
Alfentanil ...................
Remifentanil ..............
Sufentanil ..................
Drug
code
Schedule
1100
1724
7379
9193
9220
9737
9739
9740
II
II
II
II
II
II
II
II
The company plans to support its
other manufacturing facilities located in
West Deptford, New Jersey and
Conshohocken, Pennsylvania with
manufacturing and analytical testing.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–01507 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
18:55 Feb 06, 2019
Jkt 247001
DEPARTMENT OF JUSTICE
[OMB Number 1121–0302]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested;
Reinstatement, Without Change, of a
Previously Approved Collection for
Which Approval Has Expired: 2019
Supplemental Victimization Survey
(SVS) to the National Crime
Victimization Survey (NCVS)
Bureau of Justice Statistics,
Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice
(DOJ), Office of Justice Programs,
Bureau of Justice Statistics, will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until April
8, 2019.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Jennifer Truman or Rachel Morgan,
Statistician, Bureau of Justice Statistics,
810 Seventh Street NW, Washington, DC
20531 (email: Jennifer.Truman@
usdoj.gov; telephone: 202–514–5083;
email: Rachel.Morgan@usdoj.gov;
telephone: 202–616–1707).
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
SUMMARY:
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Reinstatement of the Supplemental
Victimization Survey (SVS), without
changes, a previously approved
collection for which approval has
expired.
(2) The Title of the Form/Collection:
2019 Supplemental Victimization
Survey (SVS) to the National Crime
Victimization Survey (NCVS).
(3) The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
The form number for the questionnaire
is SVS–1. The applicable component
within the Department of Justice is the
Bureau of Justice Statistics, in the Office
of Justice Programs.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Respondents will be persons
16 years or older living in households
located throughout the United States
sampled for the National Crime
Victimization Survey (NCVS). The SVS
will be conducted as a supplement to
the NCVS in all sample households for
a six (6) month period from July through
December 2019. The SVS is primarily an
effort to measure the prevalence of
stalking victimization among persons,
the types of stalking victimization
experienced, the characteristics of
stalking victims, the nature and
consequences of stalking victimization,
and patterns of reporting to the police.
BJS plans to publish this information in
reports and reference it when
responding to queries from the U.S.
Congress, Executive Office of the
President, the U.S. Supreme Court, state
officials, international organizations,
researchers, students, the media, and
others interested in criminal justices
statistics.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimate of the total
number of respondents is 119,526
persons age 16 or older. About 98.6%
(117,879) will have no stalking
victimization and will complete the
short interview with an average burden
of three (3) minutes. Among the 1.4% of
respondents (1,647) who experience
stalking victimization, the time to ask
the detailed questions regarding the
aspects of their stalking victimization is
estimated to take an average of 18
E:\FR\FM\07FEN1.SGM
07FEN1
]]>Agencies
[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Pages 2579-2580]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01507]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Johnson
Matthey Pharmaceutical Materials, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before April 8, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701
[[Page 2580]]
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
November 8, 2018, Johnson Matthey Pharmaceutical Materials, Inc., 25
Patton Road, Devens, Massachusetts 01434 applied to be registered as a
bulk manufacturer of the following basic classes of controlled
substances:
------------------------------------------------------------------------
Controlled substances Drug code Schedule
------------------------------------------------------------------------
Amphetamine........................... 1100 II
Methylphenidate....................... 1724 II
Nabilone.............................. 7379 II
Hydrocodone........................... 9193 II
Levorphanol........................... 9220 II
Alfentanil............................ 9737 II
Remifentanil.......................... 9739 II
Sufentanil............................ 9740 II
------------------------------------------------------------------------
The company plans to support its other manufacturing facilities
located in West Deptford, New Jersey and Conshohocken, Pennsylvania
with manufacturing and analytical testing.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-01507 Filed 2-6-19; 8:45 am]
BILLING CODE 4410-09-P
